7Baggers
 Published on: 2025-10-02 23:56:18  newser.com Fri, 03 Oct 2025 04:56:18 GMT
 Aclaris Therapeutics to host R&D Day on October 14  TipRanks Tue, 30 Sep 2025 11:17:10 GMT
 Published on: 2025-09-29 10:26:08  newser.com Mon, 29 Sep 2025 15:26:08 GMT
 published on: 2025-09-25 13:32:25  newser.com Thu, 25 Sep 2025 18:32:25 GMT
 12 best fundamentally strong penny stocks to buy right now  Insider Monkey Sat, 20 Sep 2025 17:02:30 GMT
 aclaris therapeutics to participate in two september healthcare conferences  Investing News Network Wed, 10 Sep 2025 17:20:28 GMT
 aclaris to present additional data on atopic dermatitis drug at eadv  Investing.com Canada Wed, 10 Sep 2025 05:45:03 GMT
 Aclaris Therapeutics Announces Late-Breaking Abstract and  GlobeNewswire Tue, 09 Sep 2025 07:00:00 GMT
 Aclaris Therapeutics at H.C. Wainwright: Strategic Pipeline Insights  Investing.com Tue, 09 Sep 2025 07:00:00 GMT
 aclaris to present additional data on atopic dermatitis drug at eadv  Investing.com Tue, 09 Sep 2025 07:00:00 GMT
 aclaris at cantor global healthcare: strategic pipeline insights  Investing.com Wed, 03 Sep 2025 07:00:00 GMT

Aclaris Therapeutics, Inc
(NASDAQ:ACRS) 

ACRS stock logo

Aclaris Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on developing drug candidates for immuno-inflammatory diseases in the United States. The Company operates in two segments, Therapeutics and Contract Research. Its products pipeline includes ATI-450, an investigational or...

Founded: 2012
Full Time Employees: 75
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends